Radionuclide therapy in oncology
- 31 January 1994
- journal article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 20 (1) , 51-71
- https://doi.org/10.1016/0305-7372(94)90010-8
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- A phase II study of treatment of painful multifocal skeletal metastases with single and repeated dose samarium-153 ethylenediaminetetramethylene phosphonateEuropean Journal of Cancer and Clinical Oncology, 1991
- A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to boneEuropean Journal of Cancer and Clinical Oncology, 1991
- 153Sm-EDTMP and 186Re-HEDP as bone therapeutic radiopharmaceuticalsInternational Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1987
- Treatment of metastatic bone pain with strontium-89International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1987
- REDUCED MORBIDITY FROM SKELETAL METASTASES IN BREAST CANCER PATIENTS DURING LONG-TERM BISPHOSPHONATE (APD) TREATMENTThe Lancet, 1987
- Lethal, Potentially Lethal, and Nonlethal Damage Induction by Heavy Ions in Cultured Human CellsRadiation Research, 1985
- Relation between Effective Radiation Dose and Outcome of Radioiodine Therapy for Thyroid CancerNew England Journal of Medicine, 1983
- Pain in far-advanced cancerPain, 1982
- Scintigraphic Localization of PheochromocytomaNew England Journal of Medicine, 1981
- 32P-Therapie des malignen PerikardergussesOncology Research and Treatment, 1980